There is some good news concerning animal testing in the cosmetics industry.
The Industrial Chemical Bills 2017, has in March 2019, been passed through the Senate and the House of Representatives - officially banning the testing of some cosmetics and their ingredients on animals, as well as the sale of cosmetics and their ingredients (from overseas) which have been newly tested on animals. The ban comes into effect in July 2020. However if the ingredient to be tested is a multi-purpose ingredient this ban does not apply. Clearly more work needs to be done here. The new legal situation is explained in: https//

This Bill has been delayed for some time due to the negotiation of 'loopholes' to ensure the legislation was meaningful. Agreement was finally reached with Human Society International (partner of Humane Research Australia) and includes a commitment by the Government to 11 substantial reinforcing measure to ensure that all cosmetic ingredients are captured by the ban, together with funding to support the development and uptake of modern non-animal test methods.

The Lush company continues to give very generous support for work to replace animal testing.
Since 2012, 2.19 million pounds have been awarded in prizes for researchers in different parts
of the world working towards this aim. To cite their website - - 'We seek to
reward those working on replacing, rather than reducing or refining animal experiments'. Nominations are now open for Lush Prize 2020. The prize fund is 250 pounds. Lush have also added a 'Future Project' award within Public Awareness to help organisations fund a new initiative and a non-financial 'Political Achievement Award' to recognise the essential work that politicians do to create lasting legal change for animals and science.

In the first competitive call for applications under the Australian Federal Governments's $500 million Genomcis Health Futures Mission, the Health Minister, Greg Hunt announced in March, 2019 that $65 million will be available over three years for research into Cancers ($15 million); paediatric acute care genomic research ($15 million) and ethical, legal and social issues related to genomics in health care ($3.7 million). A further $32 million will be available over four years for research into pathogen genomics, including infectious respiratory diseases. Contact: Ph. 132846; Applications closed 31 May, 2019.

New book: Animal Experimentation: Working Towards a Paradigm Change : There is growing understanding that human-relevant data is needed for the understanding and possible treatment of chronic, complex disease, many of which are not well understood and, thus, cannot be readily modeled in non-human animals. The technology revolution has greatly changed the field of life sciences and now provides us with tools enabling a shift away from animal experimentation. The 51 experts who have contributed to Animal Experimentation: Workring Towards a Paradigm Change (2019, Brill open access) review current animal use in science, and they discuss innovative, human-relevant approaches to advance the life sciences and to accelerate the shift towards the replacement of animals in research, testing and education.

In what may be a first for artificial intelligence uses in medical research, a computer (called Sam who lives at Flinders University) has used its own brain power to design a new drug for human use against influenza. It will now be trialed in the U.S. (July, 2019).